Legendary Entertainment Launches Dune: Future Artifacts, Featuring the Extraordinary Score of Academy Award® Winning Composer, Hans Zimmer
10.9.2021 19:25:00 EEST | Business Wire | Press release
Legendary Entertainment:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210910005448/en/
Dune: Future Artifacts, the digital NFT collection http://dunemovie.com/futureartifacts (Photo: Business Wire)
What: In celebration of the Fall release of Warner Bros. Pictures and Legendary Pictures’ blockbuster film event Dune, Legendary Entertainment, in collaboration with iv gallery, Lineage Studios, and MakersPlace will present an official Dune NFT collection of digital artifacts inspired by the rich world of Denis Villeneuve’s highly anticipated film. This wide-reaching collection, packed with surprises, will include artifacts capturing humanity’s “future history”, from detailed in-world royal portraits of iconic characters taken from the hallowed halls of House Atreides and House Harkonnen to towering sculptures and artifacts unearthed from the shifting sands of Arrakis – known to its inhabitants as Dune.
The Current Dune: Future Artifacts Collection Set to Drop on September 22 features:
- Digital Sculptures – Dune’s most iconic characters, crafted in the likeness of the film’s all-star cast including two editions of Paul Atreides (Timothée Chalamet), Chani (Zendaya), Baron Vladimir Harkkonen (Stellan Skarsgård), Lady Jessica (Rebecca Ferguson), Duncan Idaho (Jason Momoa) and Duke Leto (Oscar Isaac).
- Hans Zimmer’s Dune Score – Every digital sculpture is elevated by the accompaniment of excerpts from the groundbreaking original score of world-renowned composer, Hans Zimmer.
- Spice Artwork – Fans will also have an opportunity to obtain a special limited-edition piece of art celebrating Spice, because as every Dune aficionado knows, he who controls the Spice controls the universe.
The Expanded Collection, Set to Drop in the Coming Weeks (Dates to be Announced):
The excitement of the Dune: Future Artifacts program will continue with additional drops featuring memorabilia and art meant to complete this thrilling digital museum.
Pieces to include…
- A special collection of original pieces from well-known digital artists such as Boss Logic, Matt Griffin and NFN Kalyan
- Additional digital statue sculpts
- Special in-world weaponry, including the storied crysknife
When: The collection launches on September 22nd, with additional artifacts being launched throughout the month of October.
Where: The adventure begins at http://www.dunemovie.com/futureartifacts.
Why: “This collection represents an exciting new direction in the NFT space,” said James Ngo, Executive Vice President of Franchise Management for Legendary Entertainment. “We are thrilled to have created a new collectible experience for the fandom by using exclusive assets taken directly from the film to give enthusiasts a whole new way to not only acquire film memorabilia but also further immerse themselves into the world of Dune.
ABOUT DENIS VILLENEUVE’S DUNE FILM
OSCAR® nominee Denis Villeneuve directed Warner Bros. Pictures and Legendary Pictures’ Dune. The film stars OSCAR® nominee Timothée Chalamet, Rebecca Ferguson, Oscar Isaac, OSCAR® nominee Josh Brolin, Stellan Skarsgård, Dave Bautista, Stephen McKinley Henderson, Zendaya, Chang Chen, David Dastmalchian, Sharon Duncan-Brewster, with OSCAR® nominee Charlotte Rampling, with Jason Momoa, and OSCAR® winner Javier Bardem. Villeneuve directed Dune from a screenplay by Jon Spaihts and Villeneuve and OSCAR® winner Eric Roth, based on the novel of the same name written by Frank Herbert. The film’s producers were OSCAR® nominee Mary Parent, Villeneuve, Cale Boyter and Joe Caracciolo, Jr. The executive producers were Tanya Lapointe, Joshua Grode, Herbert W. Gains, Jon Spaihts, Thomas Tull, Brian Herbert, Byron Merritt and Kim Herbert, with Kevin J. Anderson as special consultant. Warner Bros. Pictures and Legendary Pictures Present a Legendary Pictures Production, a Film by Denis Villeneuve, Dune. The film is slated to be released worldwide this fall, in theaters from 15 September internationally and in the U.S. on October 22 in both theaters and on HBO Max; it will be available on HBO Max in the Ad-Free plan for 31 days from theatrical release. The film has been rated PG-13 for sequences of strong violence, some disturbing images and suggestive material.
ABOUT HANS ZIMMER’S DUNE SCORE
Legendary composer and lifelong Dune fan Hans Zimmer has composed THREE albums of music for Warner Bros. Pictures and Legendary Pictures’ Dune. Now available is the digital album The Dune Sketchbook (Music from the Soundtrack) , which is comprised of extended, immersive musical explorations of the “Dune” film score. September 17th will see the digital album release of Dune (Original Motion Picture Soundtrack) , featuring the iconic composer’s “Dune” film score. And October 22nd is the digital release date for The Art and Soul of Dune - the companion soundtrack to the book of the same title, offering uniquely crafted versions of the film’s main themes curated by Zimmer.
ABOUT LEGENDARY ENTERTAINMENT
Legendary Entertainment is a leading media company with film (Legendary Pictures), television and digital (Legendary Television and Digital Media) and comics (Legendary Comics) divisions dedicated to owning, producing and delivering content to worldwide audiences. Legendary has built a library of marquee media properties and has established itself as a trusted brand which consistently delivers high-quality, commercial entertainment including some of the world's most popular intellectual property. In aggregate, Legendary Pictures-associated productions have realized grosses of more than $18 billion worldwide at the box office. To learn more visit: www.legendary.com.
ABOUT MAKERSPLACE
MakersPlace is the premier NFT marketplace for digital art. Launched in 2018, MakersPlace utilizes blockchain technology to facilitate the sale of authentic, original digital artwork, ensuring rarity and ownership for both creators and collectors. MakersPlace has emphasized accessibility since its inception, and has attracted a large mainstream audience as the first NFT marketplace to accept both cryptocurrency (ETH) and non-cryptocurrency (USD) payments, which it facilitates through crypto wallet and credit card transactions, respectively. MakersPlace helped catapult digital art and NFTs onto the global stage, with the historic sale of Beeple’s Everydays: The First 5000 Days for $69.3 million in partnership with Christie’s auction house in March 2021 – the record price for any digital artwork. Our mission is simple: to enable a vibrant future for digital creativity.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210910005448/en/
Contact information
Brie Dorsey
818-940-2105
bdorsey@legendary.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 16:13:00 EET | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of disease progression or death compared with standard chemoimmunotherapy. Full results from the MANGROVE study will be presented during the Plenary Scientific Session at the 68th American Society of Hematology (ASH) Annual Meeting on December 13, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103605806/en/ BeOne Medicines' flagship U.S. manufacturing and clinical R&D facility at the P
Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 16:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstracts at the 2026 American Society of Hematology (ASH) Annual Meeting, to beheld December 12 – 15, 2026, in New Orleans. “Our ASH presentations demonstrate meaningful progress across our Hematology portfolio to advance novel treatment approaches for people with serious hematologic conditions,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "We are particularly encouraged by the continued clinical progress of INCA033989 in myelofibrosis (MF) and essential thrombocythemia (ET) and the data for latarcibart in von Willebrand disease (VWD) - data that support our goal of advancing differentiated medicines with the potential to meaningfully improve outcomes for patients." Details on key data presentations at ASH include: Oral Presentations INCA033989 (mutCALR) In JAK-Inhibitor Naive Patients with Myelof
Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 16:00:00 EET | Press release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMware and IBM environments, without having to go through a lengthy individual tender process. Through Rimini Support™, organizations gain access to a support alternative enabling them to significantly reduce their historical support costs, improve service quality and support respons
Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 16:00:00 EET | Press release
Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e
Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 15:41:00 EET | Press release
Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom